Sedana Medical AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	196.15	200.23	178.75	153.87	122.87	159.15
Revenue Growth (YoY)	4.66%	12.01%	16.17%	25.23%	-22.80%	12.26%
Cost of Revenue	56.33	57.52	52.61	44.89	36.79	52.45
Gross Profit	139.83	142.71	126.14	108.98	86.07	106.71
Selling, General & Admin	151.8	154.66	156.6	154.74	169.94	148.31
Research & Development	20.95	20.62	20.29	20.81	19.94	19.7
Other Operating Expenses	-0.01	-0.01	0.03	-0.02	0.12	-0.11
Operating Expenses	172.73	175.26	176.92	175.53	190.01	167.9
Operating Income	-32.91	-32.55	-50.78	-66.55	-103.93	-61.2
Interest Expense	-	-1.45	-0.18	-0.22	-0.26	-0.24
Interest & Investment Income	21.99	3.38	16.49	15.17	3.58	-
Currency Exchange Gain (Loss)	-26.09	-26.64	24.52	-7.42	27.68	4.07
Other Non Operating Income (Expenses)	0	0	-0	-	-	-
Pretax Income	-37.01	-57.26	-9.95	-59.02	-72.93	-57.37
Income Tax Expense	2.51	1.98	0.73	0.59	0.57	0.6
Net Income	-39.52	-59.24	-10.67	-59.61	-73.51	-57.97
Net Income to Common	-39.52	-59.24	-10.67	-59.61	-73.51	-57.97
Shares Outstanding (Basic)	99	99	99	99	99	93
Shares Outstanding (Diluted)	99	99	99	99	99	93
Shares Change (YoY)	-	-	-	-	6.85%	1.54%
EPS (Basic)	-0.40	-0.60	-0.11	-0.60	-0.74	-0.62
EPS (Diluted)	-0.40	-0.60	-0.11	-0.60	-0.74	-0.62
Free Cash Flow	-18.61	-15.18	-13.99	-38.58	-116.17	-46.41
Free Cash Flow Per Share	-0.19	-0.15	-0.14	-0.39	-1.17	-0.50
Gross Margin	71.28%	71.27%	70.57%	70.83%	70.06%	67.05%
Operating Margin	-16.78%	-16.26%	-28.41%	-43.25%	-84.59%	-38.45%
Profit Margin	-20.15%	-29.59%	-5.97%	-38.74%	-59.83%	-36.42%
Free Cash Flow Margin	-9.49%	-7.58%	-7.82%	-25.07%	-94.55%	-29.16%
EBITDA	-28.61	-30.41	-47.2	-64.19	-100.56	-56.8
EBITDA Margin	-14.59%	-15.19%	-26.41%	-41.72%	-81.84%	-35.69%
D&A For EBITDA	4.3	2.15	3.58	2.36	3.38	4.4
EBIT	-32.91	-32.55	-50.78	-66.55	-103.93	-61.2
EBIT Margin	-16.78%	-16.26%	-28.41%	-43.25%	-84.59%	-38.45%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.